Study identifier:D1690R00044
ClinicalTrials.gov identifier:NCT03549754
EudraCT identifier:N/A
CTIS identifier:N/A
Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases
Type 2 Diabetes
N/A
No
-
All
35000
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|